Bayer’s blockbuster ambitions for diabetic kidney disease (DKD) drug candidate finerenone look a lot firmer with the publication of data from the phase 3 FIDELIO-DKD trial. Bayer teased the top-line result from the study back in July, providing the first clue that its sizeable investment… Read More »Bayer data for kidney disease hope finerenone sets up filings
What You Should Know: – Today, Blue Cross and Blue Shield of North Carolina partners with Carrot Inc. and Virta Health to help address two of the largest ongoing health issues facing Americans today – smoking and type 2 diabetes. – Virta and Carrot’s programs… Read More »Blue Cross NC Launches No-Cost Virtual Programs to Quit Smoking and Reverse Diabetes
Date: October 19, 2020 Issue #: 1609 Summary: The FDA has approved two additional doses (3 mg and 4.5 mg) of the glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide (Trulicity – Lilly) for treatment of type 2 diabetes in adults. Dulaglutide has been available in 0.75-… Read More »Two New Doses of Dulaglutide (Trulicity) for Diabetes
What You Should Know: – Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. – By making this crucial expansion, Virta can scale its treatment to support the tens of millions of additional patients with… Read More »Virta Expands Offerings to Treat New Group of Chronic Illnesses
What You Should Know: – NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several unusual forms of diabetes. – RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that… Read More »NIH Funds First Nationwide Rare and Atypical Diabetes Network
Date: October 19, 2020 Issue #: 1609 Summary: The FDA has approved insulin lispro-aabc (Lyumjev – Lilly), a faster-acting formulation of insulin lispro (Humalog), for treatment of type 1 and type 2 diabetes in adults. Fiasp, a faster-acting formulation of insulin aspart (Novolog), was approved… Read More »Lyumjev – A New Insulin Lispro for Diabetes
What You Should Know: – DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a… Read More »$5M Research Grant Launches to Evaluate Efficacy of Virtual Diabetes Care
– Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services being offered to patients. – To date, the company has treated more than a million patients online for a variety… Read More »Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform
